Using The Rat Grimace Scale to Detect Orofacial Pain in Mechanically-induced Temporomandibular Joint Pain in Rats by Yu, Ya-Hsin et al.
University of Pennsylvania
ScholarlyCommons
Dental Theses Penn Dental Medicine
Spring 6-14-2018
Using The Rat Grimace Scale to Detect Orofacial
Pain in Mechanically-induced Temporomandibular
Joint Pain in Rats
Ya-Hsin Yu
University of Pennsylvania, yayu@upenn.edu
Megan M. Sperry
University of Pennsylvania, sperrym@seas.upenn.edu
Beth A. Winkelstein
University of Pennsylvania
Eric J. Granquist
University of Pennsylvania
Follow this and additional works at: http://repository.upenn.edu/dental_theses
Part of the Dentistry Commons
This paper is posted at ScholarlyCommons. http://repository.upenn.edu/dental_theses/27
For more information, please contact repository@pobox.upenn.edu.
Recommended Citation
Yu, Ya-Hsin; Sperry, Megan M.; Winkelstein, Beth A.; and Granquist, Eric J., "Using The Rat Grimace Scale to Detect Orofacial Pain in
Mechanically-induced Temporomandibular Joint Pain in Rats" (2018). Dental Theses. 27.
http://repository.upenn.edu/dental_theses/27
Using The Rat Grimace Scale to Detect Orofacial Pain in Mechanically-
induced Temporomandibular Joint Pain in Rats
Abstract
Introduction: Orofacial pain in animal models of TMJ disorders is typically evaluated by measuring evoked
reflexive responses. Since the rat grimace scale (RGS) was adopted recently to assess spontaneous pain in
other pathologies, this study evaluated its effectiveness for TMJ pain in the rat. RGS was evaluated using a
well-defined pain model of TMJ loading.
Material and Methods: Female Holtzman rats were assigned to separate groups: loading (n=10); sham
(n=4); loading with naproxen (n=4) or vehicle (n=3) on days 4 and 5 after pain developed. Jaw loading was
imposed for 7 consecutive days under anesthesia by repeated mouth-opening for 1hr. Sham had no mouth-
opening. Naproxen or vehicle (1mg/kg) was given intravenously. Rats were videotaped for 30mins daily after
loading, and for 7 days after loading was stopped. Images were randomized and quantitatively scored using 4
action units: orbital tightening, nose/cheek flattening, ear change, whisker change. The RGS score was
compared between groups using a repeated-measures ANOVA and Tukey's post-hoc test.
Results: Loading induced significantly higher (p<0.001) RGS scores than sham on days 1 and 5. After loading
was stopped, RGS scores returned to sham levels for the remainder of test days. Naproxen injection
significantly lowered (p<0.001) RGS scores from loading alone on day 7.
Conclusion: Orofacial pain can be detected by the RGS, which may provide a useful new method to evaluate
TMJ pain.
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ABSTRACT 
Using The Rat Grimace Scale to Detect Orofacial Pain in Mechanically-
induced Temporomandibular Joint Pain in Rats 
Ya-Hsin Yu
Megan M. Sperry, Beth A. Winkelstein, Eric J. Granquist
Introduction
Orofacial pain in animal models of TMJ disorders is typically evaluated by measuring evoked 
reflexive responses. Since the rat grimace scale (RGS) was adopted recently to assess 
spontaneous pain in other pathologies, this study evaluated its effectiveness for TMJ pain in the 
rat. RGS was evaluated using a well-defined pain model of TMJ loading. 
Material and Methods
Female Holtzman rats were assigned to separate groups: loading (n=10); sham (n=4); loading 
with naproxen (n=4) or vehicle (n=3) on days 4 and 5 after pain developed. Jaw loading was 
imposed for 7 consecutive days under anesthesia by repeated mouth-opening for 1hr. Sham had 
no mouth-opening. Naproxen or vehicle (1mg/kg) was given intravenously. Rats were videotaped 
for 30mins daily after loading, and for 7 days after loading was stopped. Images were randomized 
and quantitatively scored using 4 action units: orbital tightening, nose/cheek flattening, ear 
change, whisker change. The RGS score was compared between groups using a repeated-
measures ANOVA and Tukey's post-hoc test. 
Results
Loading induced significantly higher (p<0.001) RGS scores than sham on days 1 and 5. After 
loading was stopped, RGS scores returned to sham levels for the remainder of test days. 
Naproxen injection significantly lowered (p<0.001) RGS scores from loading alone on day 7. 
Conclusion
Orofacial pain can be detected by the RGS, which may provide a useful new method to evaluate 
TMJ pain. 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LITERATURE REVIEW 
Anatomy of the temporomandibular joint 
The bilateral temporomandibular joints (TMJs) play an important role in facilitating and limiting the 
articulation between the cranium, mandible and upper cervical spine. Each TMJ is a synovial 
joint, composed of a fibrocartilaginous disc and articular cartilage covered condyle. The bony part 
of the TMJ is formed by the condyle of the mandible, which inserts into the glenoid fossa of the 
temporal bone (Figure 1). The articular disc lies between the two bony components. The disc is 
biconcave and is made up of dense fibrous connective tissue attached to bilaminar zone which is 
richly vascularized and innervated. Collateral ligaments are attached to both the medial and the 
distal sides of the mandibular condyle, which keep the disc in place relative to the head of the 
condyle during movements without displacement (Meyenberg et al. 1986). 
The movement of the upper joint space is mainly associated with translations of the condyle and 
the lower joint space is responsible for condyle rotation. Several muscles permit those frictionless 
translation and rotation movements, typically allowing for painless and efficient functional 
movements, including chewing, swallowing, and speaking. Such anatomical characteristics not 
only allow the joint to move back and forth in one plane, but also permit gliding movements 
between the temporal and mandibular articular bone (Alomar et al. 2007). The primary muscles 
that provide mandibular movements are the masticatory muscles, which include the masseter 
muscle, the medial pterygoid muscle, the lateral pterygoid muscle, and the temporal muscle 
(Figure 2). There are additional muscles associated with neck and head, supporting movements 
(Scrivani et al. 2008). Parafunctional behaviors, such as bruxism — which is the abnormal wear 
on the dentition that results from continuous grinding and clenching pressures — can involve the 
muscles of the TMJ (Glaros et al. 1977). Other parafunctional habits include grinding of the teeth, 
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clenching, empty-mouth movements and other non-functional, involuntary mandibular 
compensatory movements (Glaros et al. 1977, Scrivani et al. 2008) . Because the joint capsule 
and surrounding muscles are innervated by nociceptive fibers, they may be sources of pain in 
TMJ disorders (Buescher 2007).
  
Figure 1. The anatomy of TMJ associated tissue
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Figure 2. The anatomy of TMJ and its associated tissues
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Overview of pain 
Pain is defined as, “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey et al. 1994). 
Approximately 9% of the adult population in the United States suffers from moderate to severe 
non-cancer related chronic pain (Jeffery et al. 2011). Even more people (10% to 20% of the 
population) report having persistent pain lasting over three months (Gureje et al. 1998,  Verhaak 
et al.1998, Blyth et al. 2001, Gatchel et al. 2006), which is defined as “chronic” pain. People older 
than 50-years-old are twice as likely to be diagnosed with chronic pain as compared to the 
younger population (Gatchel et al. 2006). Management of chronic pain is an important clinical 
issue, particularly for the future health care of aging population (Campbell et al. 2006, Gatchel et 
al. 2006). Accurate and reliable clinical questionnaires and scales are used to evaluate pain using 
human self-ratings  (Price et al. 1983). However, studies are challenging not only because they 
are fundamentally subjective but also ethically self-limiting (Mogil 2009). New techniques, such as 
functional-imaging scans or genetic biomarkers, are being developed that may provide both 
reliable and more objective measurements to study pain in the future. For now, non-human 
animals are widely used in pain studies (LeBars et al. 2001, Mogil 2009). 
Pain is multi-factorial and dynamic, made more complex since inhibition and nociceptive 
amplification can take place at many places in the central nervous system (CNS) with synaptic 
communication. Pain can be classified into three major categories from a neurobiological 
perspective: (1) nociceptive pain; (2) inflammatory pain; and (3) pathological pain. Nociceptive 
pain and inflammatory pain are both adaptive and protective, while pathological pain is 
maladaptive, resulting from abnormal functioning of the nervous system (Woolf 2010). 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(1) Nociceptive pain 
The most common type of pain is nociceptive pain, brought on by sensing noxious stimuli. A 
nociceptor is a high-threshold pain receptor only activated by intense stimuli. Nociceptive pain 
produces an autonomic response and withdrawal reflex. If something extremely cold or hot or 
something sharp is touched, the terminals of the nociceptive nerve will induce a protective 
response (Woolf 2010). First-order nociceptive afferents (primary sensory neurons) collect 
information about non-noxious and noxious stimuli, and are classified into four major groups. 
Large diameter, myelinated fibers (A-𝛼 and A-𝛽 fibers) conduct the fastest. A-ẟ fibers are lightly 
myelinated; and unmyelinated C fibers are the slowest responders (Milligan et al. 2009). 
Normally, A-𝛽 fibers only respond to low-frequency and non-noxious stimulation (Torebjork et al. 
1992), which are interpreted as light touch. However, A-𝛽 fibers can begin to transmit pain signals 
after injury (Woolf 2010). Nociceptive neurons contain a bifurcating axon, with A-ẟ fibers and C 
fibers projecting to nociceptive interneurons and second-order pain-projection neurons in the 
dorsal horn of the spinal cord (Figure 3) (Mannion et al. 2000). A-ẟ fibers and C fibers both 
respond to high-frequency and painful mechanical stimuli (Merrill et al. 2007). A-ẟ fibers transmit 
impulses faster than C fibers due to their myelination. C fibers stimulate second-order neurons to 
release many different kinds of neurotransmitters, which can maintain persistent pain (Mannion et 
al. 2000, Bolay et al. 2002, Merrill et al. 2007, Milligan et al. 2009). If there is no stimulus that is 
potentially noxious, the nociceptors are normally silent. However, nociceptors become 
hypersensitive and develop pathological spontaneous activity after peripheral nerve injury (Woolf 
2010). Spontaneous pain in the absence of external stimuli can occur and is believed to be due to 
increased messenger RNA for voltage-gated sodium channels in primary afferent neurons, 
lowering the threshold for generating an action-potential leading to revival in hyperactivity (Lai et 
al, 2003, Merrill et al. 2007, Milligan et al. 2009, Woolf 2011).
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 Figure 3. Activation of nociceptive nerve fibers and spinal transmission 
First-order nociceptive afferents  in the periphery (primary sensory neurons) collect information 
about non-noxious and noxious stimuli: A-𝛽 fibers (yellow), A-ẟ fibers (blue), and C fibers (red). A-
ẟ fibers and C fibers project to nociceptive interneurons and second-order pain-projection 
neurons (green) in the dorsal horn of the spinal cord.
(2) Inflammatory pain 
Inflammatory pain can be caused by tissue injury or infection which activates the immune system 
response (Woolf 2011). Inflammation of peripheral tissue is believed to be associated with the 
release of chemical mediators from cells or from the nociceptive afferent endings themselves. 
Spreading the mediators through the tissue, the adjacent tissue will also has the same reaction 
inflammation reaction (Sessle 2011). Inflammatory reactions can be protective and help in healing 
by creating a protected environment through discouraging physical contact, such as in 
rheumatoid arthritis or cases of extensive injury. The inflammatory pain comes with tenderness, 
spontaneous pain and/or pain hypersensitivity to reduce the risk of damage and promote 
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recovery (Woolf 2010). Nociceptive pain and inflammatory pain are usually short-term, while the 
pathological pain often last months to years (Mogil 2009).
(3) Pathological pain 
Pathological pain is associated with inflammation and/or trauma of peripheral tissues or nerves 
after injury. There are different mechanisms to cause pathological pain. When injury or 
inflammation is prolonged and causes tissue damage, noxious stimuli are no longer required to 
induce the pain, Woolf defined this as “dysfunctional pain” (Woolf 2011). If the inflammation or 
injury damaged neural tissue, it is called “neuropathic pain” (Milligan et al. 2009). 
Normally, acute pain processing begins with stimuli that activate specialized receptive endings on 
peripheral sensory nerve fibers. Acute pain is self-limited, inducing an adaptive and protective 
response which helps to prevent further tissue damage (Jeffery et al. 2011, Woolf 2011). Acute 
pain results from a transient, high-intensity activation of specialized receptive endings on 
nociceptive sensory fibers which often leads to tissue damage  (Milligan et al. 2009). When injury 
or inflammation is prolonged, primary nociceptive neurons can become hyper-excitable, causing 
chronic pain. The CNS can also sensitize neurons in the spinal cord, leading to chronic pain 
(Milligan et al. 2009). Different from acute pain, chronic pain is considered to be a disease 
condition (Mogil 2009). Chronic pain has negative effects on many aspects of quality of life. 
Patient with long-lasting pain have a higher chance to experience negative emotions and to 
distrust people around him/her (Mienna et al. 2012). In one European survey, 19% of the adult 
population suffered from moderate to severe chronic pain, and their daily activities, social and 
working lives were seriously affected (Breivik et al. 2006). 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Temporomandibular joint disorders 
Temporomandibular joint disorders (TMD) is a group of musculoskeletal, neuromuscular, and 
combined conditions associated with the tissues in and surrounding the TMJ (Buescher et al. 
2007, Alomar et al. 2007, Scrivani et al. 2008). The earliest study of TMD is reported by an 
otolaryngologist — James Costen. He described a syndrome of ear and sinus symptoms related 
to loss of lower posterior teeth and mandible over-closure (Costen et al. 1934). In 1982, the 
American Dental Association (ADA) defined TMJ disorders as a craniomandibular disorder (CMD) 
(Griffiths et al. 1983). TMD is a major cause of non-odontogenic pain in the orofacial region, with 
the primary presenting symptom of pain, localized to the masticatory muscles and/or pre-auricular 
area. In addition to pain, TMD patients also frequently present with limited jaw movement and 
TMJ sounds (De Leeuw and Klasser 2013).
The overall prevalence of TMJ disorder is over 5% (Liu et al. 2013). In the United States (US), the 
prevalence of TMJ disorder is 8.4%, and 6% of the US population has a symptom involving joint 
pain (Lipton et al. 1993). Another study reports the prevalence of TMJ pain in women in the US as 
estimated to be 10.5% (Janal et al. 2008). One of the most prevalent TMJ pathologies is 
osteoarthritis (OA) (Scrivani et al. 2008). TMJ-OA leads to low-grade inflammation and joint 
degeneration, and it is often associated with persistent pain (Stegenga et al. 1989, Scrivani et al. 
2008). Previous result has shown that 19% of the dental students at Umeå University in Sweden 
have persistent signs and/or symptoms from the TMJ in a 2-year follow up period (Marklund et al. 
2010). Females have twice the likelihood of persistent TMJ signs or symptoms compared to 
males (LeResche et al. 1997, Marklund et al. 2010, Anastassaki Kohler et al. 2012). Initial 
treatment for treating TMD patients is noninvasive therapy, including rest, occlusal appliances, 
heat, muscle relaxants, nonsteroidal antiinflammatory drugs (NSAIDs), and physical therapy 
(Scrivani et al. 2008). However, persistent TMJ pain is a challenge for clinical management 
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because it cannot always be resolved through traditional courses of treatment. Surgical 
interventions, such as intra-articular injection with steroids, arthrocentesis, or arthroscopy, is 
needed in patients with persistence of high levels of pain and mandibular dysfunction (Scrivani et 
al. 2008, Israel et al. 2010). 
Functional brain imaging, including positron emission tomography (PET) and functional magnetic 
resonance imaging (fMRI), are used in more recent studies to understand the functional and 
structural changes in the CNS. fMRI demonstrates changes in cortical brain circuitry in TMD 
patients, supporting the hypothesis that TMJ disorder is similar to other chronic pain disorders (de 
Leeuw et al. 2005). TMD patients may also have different pain processing than normal in the 
trigeminal system, a phenomenon known as “central sensitization” (Merrill et al. 2007, Scrivani et 
al. 2008, Woolf 2011). Central sensitization is a condition in which the somatosensory pathways 
exhibit enhanced synaptic efficacy and decreases in inhibition (Woolf 1983). As a result, patients 
develop a lower central threshold to noxious stimuli (hyperalgesia) or/and have pain to non-
noxious stimuli (allodynia) (Iwata et al. 1999, de Leeuw et al. 2005, Woolf et al. 2011). In addition, 
different studies suggest that there is a connection between chronic TMJ disorders and coexisting 
psychopathology conditions such as anxiety, depression, and physical abuse histories (Campbell 
et al. 2000, Ferrando et al. 2004). Early detection of psychological symptoms could enable 
adequate treatment earlier to slow down the development of psychological symptoms (Ferrando 
et al. 2004). Overall, the etiology of TMJ disorder remains unclear. However, it is considered to be 
multifactorial disorder, with physiological and psychological components (Scrivani et al. 2008).
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Animal models of TMJ pain 
Different animal models have been developed to study TMJ disorder. TMD studies use different 
species including rodents, rabbits, pigs, sheep, goats, and cattle. In recently studies, rats are 
widely used due to the research involving nociceptive and nervous system in rats increase rapidly 
(Herring 2003). There are only minor differences in anatomy between rats and human: the angles 
between the condyle and the mandible corpus, condyle axis, and there are no anterior eminence 
in rats’ temporal fossa. Overall, rats are easy to handle and the TMJ structure is also comparable 
to human (Orset et al. 2014).
There are two main ways used to induce TMD: chemical approaches and surgical or mechanical 
approaches (Almarza et al. 2011).  For chemical approaches, chemical agents are injected into 
the TMJ region (Roveroni et al. 2001, Krzyzanowska et al. 2012). There are different chemical 
agents in the chemical approaches: Complete Freund’s Adjuvant (CFA), mustard oil, formalin, 
and carrageenan. CFA is heat-killed Mycobacterium tuberculosis  in an oil and saline emulsion, 
and can produce acute inflammation. CFA-induced allodynia can last up to 18-days (Ren 1999, 
Iwata et al. 1999, Hutchins et al. 2000). Contacting to formaldehyde results in the DNA-protein 
cross-links formed, primary genotoxic effect,  which cause tissue inflammation (Lu et al. 2010). 
However, the effect of formalin only lasts for about 45minutes (Roveroni et al. 2001, Clemente et 
al. 2004, Gamerio et al. 2005, Almarza et al. 2011). Both mustard oil and carrageenan are used to 
irritate the TMJ to create inflammation. Mustard oil is only used to alter muscle activity via 
electromyography (EMG) in a short-time (30minutes). There are no studies discussing the effect 
to the articulating tissue of the TMJ of mustard oil (Hathaway et al. 1995, Yu et al. 1996, Almarza 
et al.2011). The effect of carrageenan is usually seem within 3 hours of its application. And 
carrageenan can also prime the TMJ afferents to develop hyperalgesia (Swift et al. 1998, Oliveira 
et al. 2005, Rodrigues et al. 2006).  
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TMD is also induced by surgical or mechanical approaches. Most of the surgical procedures are 
used on larger animals, such as rabbits, monkeys, and sheep. The surgical techniques are 
including disc displacement, condylectomy, disc perforation, and discectomy (Almarza et al.2011). 
All the surgical procedures mimic more severe injury of the TMJ tissue. Various methods of 
mechanical perturbation have been used to create TMD (Almarza et al. 2011). These procedures 
are more close to mimicking how TMD is induced in reality, such as bite changes, altered dietary 
consistency, tooth extraction, and orthodontic appliance (Fujita and Hoshino 1989, Cicochon et al. 
1997, Mao et al. 1998, Liao et al. 2014). All of the above studies indicate that mechanical 
perturbation does have an effect in inducing TMD. 
However, all of the above approaches artificially damage the TMJ but are not clinically 
relevant. OA is the primary pathology of the TMD. Mechanical overloading of the TMJ is the 
major factor inducing OA onset in TMJ tissue (Stegenga et al. 1989, Israel et al. 1991). 
Several studies found that forced jaw-opening models in rabbits and rats can induce OA by 
histological evaluation (Fujisawa et al. 2003, Tanaka et al. 2005, Kawai et al. 2008). However, 
none of those studies mentioned the loading protocol details, the onset time of pain, and how 
long the pain was maintained. Our lab has developed a model of mechanically-induced TMJ 
pain in the rat to mimic the joint loading that occurs in clinical TMD to enable study of the 
orofacial pain and joint tissue responses (Nicoll et al. 2010, Kartha et al. 2016). The TMJ 
loading protocol uses mouth-opening for 1hour repeated for seven continuous days, using a 
2-N or 3.5-N load to the TMJ. The behavioral hypersensitivity increases immediately and 
persists for about 14 days. Then by 2 weeks after the loadings stopped , the threshold of 
head withdrawal gradually went back to the baseline level. Histologic findings showed 
thinning of both condylar cartilage and articular disc in the TMJ tissue after loading for 1-
week. However, there was no evidence of tissue repair in the 2-N group on day 14 despite 
behavioral hypersensitivity resolving. Ongoing work from our lab altered the jaw-opening 
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force from 2-N to 3.5-N, which is the maximum load below the biomechanical threshold for 
jaw dislodging in rats (Kartha et al. 2016). That work showed the 3.5-N loading induces a 
constant and non-resolving pain at 14-days after loading, and the head withdrawal threshold 
in the 3.5-N loading group is significant lower than the 2-N loading group on days 13 and 14. 
Also, the upregulation of the inflammatory marker, matrix metalloproteinase-13 (MMP-13), 
hypoxia-inducible factor-1a (HIF-1a), and tumor necrosis factor-𝛼 (TNF-𝛼), only in the 3.5-N 
loading group. From the results of the two studies, conditions of the forced mouth-opening 
that can create either acute (2-N loading) or persistent (3.5-N) orofacial pain, depending on 
the forced jaw-opening loading.
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Pain assessment methods 
Mechanical reflex testing 
The majority of pre-clinical pain studies assess mechanical sensitivity by measuring head 
withdrawal thresholds to von Frey filament stimulation (Ren et al. 1999, Mogil et al. 2004). That 
type of testing measures reflexes at the level of the spinal cord after a thermal, chemical, 
electrical or mechanical stimulation. Most TMJ studies measure pain using mechanical 
stimulation of the bilateral TMJ regions by von Frey filaments to measure head-withdrawal 
threshold (Ren et al. 1999, Krzyzanowska et al. 2012, Nicoll et al. 2010, Kartha et al. 2016). 
However, hypersensitivity is only one component of pain (Mogil 2009) and is only a measure of 
evoked pain. It requires trained handling of the rat during behavioral testing, and is best suited to 
acute stimuli, which assesses nociceptive pathways only. However, the evoked pain is an indirect 
way to measure the pain. It is also possible that the observed withdrawal reflexes reflect only an 
avoidance of the stimulus (Bove 2006, DeRantere et al. 2015). Although evoked behavioral 
testing is a useful measurement for pre-clinical pain studies, it is challenging to translate these 
outcomes into clinical practice. There is a survey showing patients with neuropathic pain present 
with spontaneous pain in 96% of that population, while the evoked testings — mechanical and 
thermal hypersensitivities — which were widely used in laboratory are only observed in 38-64% of 
the patients with chronic pain (Backonja et al. 2004). The prevalence of evoked pain in patients 
with chronic pain is much lower than the prevalence of non-evoked or spontaneous pain. That 
work also shined that spontaneous pain is a much better predictor of pain than the evoked 
testings (Backonja et al. 2004, Mogil 2009). 
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Spontaneous behavioral testing 
Spontaneous pain is a more common and reliable symptom reported clinically (Backonja et al. 
2004). Indeed, nerve injury produces spontaneous pain in animal models as well (Kupers et al. 
1992, Baron et al. 2000). However, it is still unknown whether it is possible to measure 
spontaneous pain in the TMJ in rodents. This is challenging because animals do not self-report 
their pain levels (Kupers et al.1992, Choi et al. 1994). Different measurements have been used in 
different studies, such as bite force, grooming behavior, guarding, and weight loss (Whittaker et 
al. 2014). However, such spontaneous behaviors are difficult to quantify, and it is also difficult to 
differentiate whether they indicate stress, pain, paresthesia, or avoidance behavior 
(Krzyzanowska et al. 2012).
Human grimace scale
Pain assessment in humans usually relies on self-reporting (Chambers et al. 2015). Many doctors 
use pain scales to gather more detailed information of patients’ pain (Williamson et al. 2005, 
Ferreira-Valente et al. 2011). The most common pain scales are the visual analog scale (VAS), 
the numerical rating scale (NRS), and the verbal rating scale (VRS). The VAS is presented as a 
100-mm line; the patient is asked to mark on the line to indicate pain intensity. The VAS, 0-mm as 
“no pain” and 100-mm as “worst imaginable pain”, provides 101 levels of pain intensity. One of 
the disadvantages of the VAS is the scale must be presented on papery. The NRS has different 
point scale (11/21/101 levels), the most widely used is the 0-10 NRS where the end points are 
extremes of “no pain” and “worst imaginable pain”. The NRS can be delivered either graphically 
or orally. The commonly used VRS is more simplified with only four categories: no pain, mild pain, 
moderate pain, and severe pain. All three scales are reliable and easy for clinical use, and the 
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NRS has good sensibility and can be statistically analysis (Chanques et al. 2010). However, all of 
the pain scales rely on self-report. For those who cannot express themselves in words — such as 
infants, young children, and verbal or cognitive impairments — facial expression can be used as 
a tool to quantify pain intensity. Ekman and Friesen developed the Facial Action Coding System, 
which transferred human facial expression movement into action units (Ekman and Friesen, 
1977). The Neonatal Facial Coding System is now widely used in infant populations (Grunau et 
al. 1987, Chambers et al. 2015). With these approaches as models, there are now several 
objective methods to evaluate expression of pain in humans. But, experiments on human are 
practically challenging and ethically self-limiting, thus, laboratory animal models are widely used 
in pain models (Mogil 2009).
Animal grimace scale
In recent years, the animal grimace scale has been developed (Chambers et al. 2015). The facial 
coding system was brought from the human to mice via the mouse grimace scale (MGS), which 
consisted of five facial features as indicators to evaluate pain (Langford et al. 2010). In that study, 
both chemical injection and surgical approaches were used to produce the pain in the mice, and 
an analgesic agent was given to reduce the pain as well. Compliantly the MGS, von Frey 
filaments were used to do mechanical reflex behavior testing. Langford’s group found that pain 
scores on the MGS were related to the intensity of stimulus. And also that there is a positive and 
linear relationship between dosage of analgesia and MGS scores. The MGS is highly accurate 
and reliable method to evaluate pain across different pain models. Moreover, both MGS and 
mechanical reflexing testing have been shown to exhibit a high positive correlation to each other 
(Leach et al. 2012). 
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Grimace scales were then developed for different species, including the rat, horse and cat, with 
high accuracy and reliability by quantifying pain through facial expression (Mogil 2009, Chambers 
et al. 2015). The rat grimace scale (RGS) was developed to evaluate spontaneous pain 
responses (Sotocinal et al. 2011). The RGS has been used in different pain models: intraplantar 
CFA injection, intra-articular kaolin/carrageenan injection, plantar incision, laparotomy, 
experimental tooth movement, and acute chemotherapy-induced mucositis (Sotocinal et al. 2011, 
Liao et al. 2014, De Rantere et al. 2015, Whittaker et al. 2016). Our lab has recently used the 
RGS to evaluate pain in a rat model of spinal nerve root compression (Philips et al. 2017). The 
RGS scores were significantly higher than the sham group, and scores remained higher than 
baseline for as long as 48 hours. The RGS in that study had a very good interobserver reliability 
and excellent internal consistency. All of the findings suggest that RGS is a useful pain 
assessment tool to identifying and monitoring acute neuropathic pain in rats. There is only one 
study using RGS to evaluate orofacial pain: orthodontic tooth movement pain (Liao et al. 2014). 
As per our knowledge, there is no evaluation TMJ pain using RGS as an assessment approach.
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Objective 
In this study, TMJ OA is induced by mechanical loading of the TMJ. TMJ pain following the 
onset of TMJ OA is evaluated using both the RGS and the mechanical reflex test (Nicoll et al. 
2010, Kartha et al. 2016, Sperry et al. 2017). Additionally, analgesic interventions are also 
used to evaluate the sensitivity of RGS measurements to TMJ disorders treatment. Pain 
associated with TMJ disorders is multifactorial, but is strongly associated with tissue 
inflammation. Naproxen, a NSAIDs, is used as a first-line pharmacologic intervention for TMJ 
disorders (Dym et al. 2016). This study evaluated if anti-inflammatory treatment has an effect 
on facial expression after TMJ pain is induced. To quantify the consistency and reproducibility 
of RGS scoring, the intraclass correlation coefficient is calculated across multiple scorers. 
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MANUSCRIPT 
Introduction 
Temporomandibular disorders (TMD) is one of the most common sources of orofacial pain 
(De Leeuw and Klasser 2013). It is defined as a subgroup of orofacial pain disorders involving 
the temporomandibular joint (TMJ), masticatory muscles, and associated head and neck 
musculoskeletal structures (Magnusson et al. 2000; Aggarwal et al. 2007). TMD can 
negatively impact on individual’s quality of life due to the symptoms of TMD, including joint 
pain and impaired jaw function (Dahlstrom et al. 2010, Mienna et al. 2012). The overall 
prevalence of TMD in the United States (US) is 8.4%, and 6% of US population has a 
symptom involving joint pain (Lipton et al. 1993). Osteoarthritis (OA) is the primary pathology 
of the TMJ, resulting in low-grade inflammation and joint degeneration (Stegenga et al. 1989; 
Israel et al. 1991). Although OA is a peripheral pathology, central sensitization also 
contributes to OA pain (Arendt-Nielsen et al. 2010). The etiology of TMD is multifactorial, with 
physiological and psychological symptoms (Scrivani et al. 2008).
Current preclinical pain research relies heavily on rat models. Mogil and his group developed the 
rat grimace scale (RGS) to evaluate and quantify the pain of chemical injection and surgical 
assays in rats using their facial expression (Sotocinal et al. 2011). The RGS has been used in 
several different pain models, including intraplantar CFA injection, intra-articular kaolin/
carrageenan injection, plantar incision, laparotomy, experimental tooth movement, and acute 
chemotherapy-induced mucositis (Sotocinal et al. 2011, Liao et al. 2014, De Rantere et al. 2015, 
Whittaker et al. 2016). Our lab has recently used the RGS to evaluate neuropathic pain in a rat 
model of spinal nerve root compression (Philips et al. 2017). RGS scores of the painful loading 
group were significantly higher than the sham group at 6hours after loading, and scores remained 
higher than baseline for as long as 48hours. The RGS in that study had a very good interobserver 
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reliability and excellent internal consistency. All of the findings suggest that RGS is a useful pain 
assessment tool to identify and monitor acute neuropathic pain in rats.  However, there are only 
one studies using RGS to evaluate orofacial pain: orthodontic tooth movement pain (Liao et al. 
2014). To our knowledge, there is no study evaluating TMJ pain using RGS as an assessment 
approach. We hypothesize that the RGS can be the used to evaluate mechanically-induced TMJ 
pain in the rat.
In this study, pain was evaluated with the RGS using a repeated mouth-opening model that 
induces sustained hyperalgesia in the TMJ region (Nicoll et al. 2010, Kartha et al. 2016). 
Naproxen, a non-steroidal anti-inflammatory drug (NSAID), is used to test if treatment has 
effect on facial expression after TMJ pain is induced. To quantify the consistency and 
reproducibility of RGS scoring, intraclass correlation was performed to evaluate the 
consistency of quantitative measurements made by different observers scoring the RGS 
values. 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Material and Methods 
Animals
All studies used adult female Holtzman rats (HsdHot:Holtzman Sprague Dawley; 250-300g at 
acquisition) obtained from Harlan Laboratories (Indianapolis, IN). Rats were housed in groups of 
two or three in standard polycarbonate caging (AnCare, Bellmore, NY), with 0.25-inch corncob 
bedding (Bed-o’Cobs; The Andersons Lab Bedding Products, Maumee, OH) and ad libitum 
access to food (LabDiet 5001; LabDiet, St Louis, MO) and water (acidified to pH=3). Rats were 
housed in an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) 
accredited vivarium under a 12:12 hour light:dark cycle in a temperature-controlled environment 
in accordance with recommendations set forth in The Guide for Care and Use of Laboratory 
Animals, 8th edition (Institute for Laboratory Animal Research 2011). All procedures were 
approved by the IACUC at the University of Pennsylvania and adhered to the guidelines for 
research and ethical issues of the International Association for the Study of Pain (IASP) 
(Zimmermann 1983).
Rats (n=23) were randomly assigned to four groups: (1) loading only (n=10); (2) loading with 
naproxen-injection (n=6); (3) loading with vehicle-injection (n=3); and (4) sham (anesthesia only, 
n=4). The sham group did not receive loaded, but all other conditions of the experiment were 
identical to the loading groups. Mechanical reflex testing for mechanical hyperalgesia took place 
at approximately 8:00 AM daily, and was before any TMJ loading (Figure 1). Three rounds of 
reflex testing were performed bilaterally, with 10 minutes of rest between each round. The rats 
were loaded with a 3.5-N weight for 1hour daily for 7 continuous days (Nicoll et al. 2010, Kartha 
et al. 2016). Digital video recordings of all four groups were collected at three hours after loading 
and the isoflurane exposure were complete (Figure 2).
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Figure 1. The overall timeline of the entire study.
The three loading groups (loading-only, loading with naproxen-injected, loading with vehicle-
injected) undergo three stages; baseline, the loading phase, and the unloading phase. In the 
loading phase, the rats were loaded with 3.5-N weight for 1hour/day for 7 continuous days (D0-
D6). For the naproxen-injected and vehicle-injected groups, the intravenous injection (inj.) was 
given immediately after loading via the lateral tail vein under isoflurane anesthesia on day 4 (D4) 
and day 5 (D5) after pain developed. Rats in the sham group were under isoflurane exposure 1-hr/
day for 7 continuous days. Both mechanical reflex testing and digital video recording were taken 
in the all three phases (baseline, loading phase, and unloading phase).
Figure 2. The daily timeline for all rats.
Mechanical reflex testing was performed in the morning at 8:00AM before any procedure. After 
evoked reflex behavioral testing, the rats were loaded with 3.5-N weight 1hour/day for 7 
continuous days. The sham group was exposed to isoflurane anesthesia but not loaded. All rats 
were digitally videotaped for 30 minutes, at least three hours after the loading/anesthesia. 
Baseline Loading phase (3.5-N, 1-hr/day for 7 days) Unloading phase
D-2 D-1 D0 D1 D2 D3 D4 D5 D6 D7 D8 D10 D12 D13
inj. inj.
1hr 3hrs 0.5h
r
0.5h
r
0.5h
r
0.5h
r
Reflex 
Testing
Loading
(n=4)
Resting
Digital video taping
(one rat at a time)
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Mechanically-induced TMJ pain
A mechanically-induced TMJ pain model in the rat was used in all experiments, as previously 
described (Nicoll et al, 2010; Kartha et al, 2016). All rats were exposed to isoflurane inhalation 
anesthesia (4-5% for induction and 2.5-3% for maintenance) during the loading procedure mixed 
with oxygen.  Rats in the loading groups were placed into an acrylic chamber in the prone 
position. The mandible was fixed with an acrylic loop and the maxilla was held open with a sling 
attached to a 3.5-N weight for 60 minutes per day (Figure 3). The procedure was applied daily for 
7 continuous days (D0-D6) (Figure 1). The loading groups received the same conditions, while 
the sham group was unloaded and received isoflurane anesthesia for 60minutes each day for 7 
continuous days (D0-D6) (Figure 1).
 
Figure 3. Methods of mechanically-inducing TMJ pain.
The mandible of the rat was fixed with an acrylic loop and the maxilla was held open with a sling 
attached to a 3.5-N weight for 60minutes each day for 7 continuous days.
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Treatment Injections
After loading, in the groups receiving treatment, an intravenous injection was performed via the 
lateral tail vein under isoflurane anesthesia on day 4 (D4) and day 5 (D5). The volume of 
administration Naproxen was given according to the weight of the rats (1mg/kg) (Jakubowski et 
al. 2007). The dose is about one-eighth of the human oral dose of 500mg recommended for 
treating patient (8mg/kg for a 60-kg person) (Jakubowski et al. 2007). The vehicle-injected group 
received only saline (control group) in the same volume. All injection procedures were performed 
by a single operator (MMS) after loading on D4 and D5, but before digital video taping for RGS 
scoring.
Mechanical reflex behavioral testing of orofacial area
Mechanical reflex testing took place at approximately 8:00 AM, before the application of loading. 
Head-withdrawal thresholds were measured by a series of von Frey filaments of increasing 
strengths from 0.6g to 60g (Nicoll et al. 2010, Kartha et al. 2016). Three rounds of reflex testing 
were performed bilaterally, with 10 minutes of rest between each round, and each strength of von 
Frey filament stimulation was applied five times to each site. The lowest-strength filament evoking 
a response was recorded as the sensitivity threshold if the next higher filament also elicited a 
response. Responses were taken as a head withdrawal or immediate pawing of the stimulated 
area. All procedures were performed by a single operator (MMS).
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Digital video recording for RGS
Rats were placed in a 23x10x10 cm3 high transparent Plexiglas chamber with a removable 
stainless steel top (Figure 4). A digital video camera (Sony HDR-CX380/B High Definition 
Handycam) was placed in front of the wider side of the box (Figure 4). Rats were videotaped for 
30minutes, 3hours after exposure to the loading/isoflurane anesthesia. All procedures were 
performed in a quiet environment and personnel remained out of visual contact with the rats for 
the duration of the recording session. The loading-only group had two subgroups for which digital 
video was taken at different time points. The L1 group underwent a short-term observation period. 
The data collected in that group were from baseline (D-2 and D-1), the 7-days of continuous 
loading (D0—D6), and the first day after loading (D7). The L2 group had a longer observation 
period; baseline (D-2 and D-1), only on four days of the 7-days continuously loading (D0, D1, D3, 
and D5), and at five times doing the rest (unloading) (D7, D8, D10, D12, and D13). The days 
picked from the loading phase is based on the data from the L1 group.
Digital video of the two injection groups were taken at the same times as L1. The sham group 
was recorded at baseline (D-1), during the loading phase (D0, D1, D5) and after unloading phase 
(D8, D13). All procedures were performed by single operator (YHY) and videos were acquired as 
mp4 files (.mp4).
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Figure 4. Set-up digital video for RGS. 
Rats were placed into a 23x10x10 cm3 high transparent Plexiglas chamber with a removable 
stainless steel top. The camera was placed at the wider side of the box. Digital video taping 
(30minutes duration) was performed three hours after loading/isoflurane exposure on those days.
Image selection and RGS scoring
Elmedia Player (Eltima Software), free software for the Mac, was used as the media player in this 
study to play the mp4 files. A total of 10-images was captured from each 30-minute video session 
at 3-minute intervals with the built-in application Image Capture (Apple), as portable network 
graphics files (png files). Images were required to have a clear view of the four action units (eyes, 
nose/cheek, ears, and whiskers) (Figure 5) and were not taken during grooming, sleeping, or 
active sniffing activity. When the images could not be extracted at the 3-minute interval, the video 
was advanced to the closest time point until the image could be used. The image-capture 
operator (YHY) was completely blinded to the groups. All of the images were inserted into 
Microsoft PowerPoint for Mac with one image per slide and a black background (Figure 6). A 
PowerPoint macro, Random Slides (http://www.tusharmehta.com/powerpoint/randomslideshow/
index.htm), was used to randomize the slide order before assessment. 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Figure 5. The four action units of the RGS.
In each individual component, a score of “0” indicated the action unit (AU) was absent. A score of 
“2” indicated there is an obvious appearance of the AU. A score “1” indicated a moderate 
appearance of the AU.
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 
Figure 6. The image capture pipeline for processing. 
10-images were captured from 30minutes of mp4 video at 3-minute intervals. Pictures were 
required to have a clear view of the rat’s eye, nose/cheek, ears, and whiskers for RGS scoring. 
The pictures were inserted into Microsoft PowerPoint for Mac with 1-image/slide and a black 
background. 
Before scoring any of the images from this study, RGS training was given to the scorer using a 
standard method, previously used to train RGS scorers from our lab team (Philips et al. 2017). 
For the training, after carefully reading the RGS scoring instruction, twenty-eight practice slides 
were used to establish scoring consensus. Each image had four scores of the RGS action units 
(AUs), including orbital tightening, nose/cheek flattening, ear change, and whisker change 
(Figure 5). The scorer assigned a value of intensity number from 0 (absent) to 2 (obviously 
present) for each of the four action units for each image. If the action units of the image could not 
be scored by the rater, the value would be assigned as “not scored”. The RGS score for each 
image is the average of the action unit scores. The mean RGS score at an individual time point is 
the average of the RGS scores across the 10-images acquired (Figure 10). All of the images 
included in this study were scored by a single observer who was blinded to treatments (YHY) 
(Figure 7).
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Figure 7. RGS scoring methods.
The four action units (AUs) were scored along a scale from 0 to 2. The RGS score of single 
image is the average of the scores from the four AUs (left). The average of 10 RGS score is the 
rat’s RGS score (right).
Comparison across RGS raters
The agreement between four trained RGS raters was calculated using the intraclass correlation 
coefficient (ICC). The ICC for the overall average RGS scores and by individual AUs were 
compared across all treatment groups from previous nerve root compression (NRC) rats model 
from our lab was used to assess variability across RGS raters. Slides (n = 230) of 6hour post-
surgery were evaluated by four scorers (BAW, BHP, CLW, and YHY). Inter-rater reliability was 
calculated with one-way random average measures. The strength of agreement was categorized 
in five groups: (1) very good (0.81-1.00); (2) good (0.61-0.80); (3) moderate (0.41-0.60); (4) fair 
(0.21-0.40); and (5) poor (<0.20) (Landis et al. 1977, Altman et al. 1990).
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Statistical analyses
All statistical analyses were performed with RStudio: Integrated Development for R (RStudio, Inc., 
Boston, MA, URL http://www.rstudio.com/). For the time-course study, the RGS score was 
compared between two groups by repeated-measures ANOVA and Tukey's post-hoc testing, with 
significance defined at a P-value of less than 0.05. RGS values are reported as mean± 1 
standard deviation. The ICC was calculated with a one-way random average measures (ICC1k). 
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Results 
A total of 2030 images was collected in this study and scored by a single blinded scorer (YHY). 
Four action units were scored in all images, and all action units were scored (no “not scored” 
action units). The baseline of RGS average value in the sham group (0.45±0.04) was not 
significantly different than the three other groups (Table 1). The RGS value of the sham group 
increased to 0.67±0.21 on day 0 after exposure to isoflurane for 1hour, but it was not significantly 
different from the baseline value (p = 0.86). The peak in RGS scores for the sham group was on 
D1 (0.79±0.13). The value decreased slightly after D1, remaining consistent with the D0 value 
(D5=0.71±0.12, D8= 0.69±0.13, and D13= 0.6±0.28). There were no significant differences from 
baseline after exposure to inhalation anesthesia at any time points (Figure 8) (Table 1).
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 Figure 8.  RGS scores for all groups in study.  
The RGS score for the three loading groups increased immediately after loading (D1). The RGS 
scores of the L1 group (red) increase until D6 with continuous 7-days loading, and once 
unloaded, the score begins to decrease. The two injected-groups with vehicle (blue) or naproxen 
(yellow) have their tail injection on D4 and D5 (red arrows).  The sham group (black) has slightly 
elevated scores after exposure to isoflurane 1hour/day. However, the RGS scores stabilize after 2 
days of exposure (D1).
#: Significant difference between the loading group and the sham group (p<0.05)
◎: Significant difference between the loading group and the naproxen-injected group (p<0.05)
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Table 1. RGS scores for all groups: the L1 group, the naproxen-injected group, the vehicle-
injected group, and the sham group.
Day Mean RGS score (0-2) Standard deviation
L1 (n=6)
Vehicle
(n=3)
Naproxe
n(n=4)
Sham
(n=4)
L1 Vehicle
Naproxe
n
Sham
Baseline
D-2 0.475 0.400 0.317 0.223 0.115 0.056
D-1 0.488 0.542 0.471 0.450 0.125 0.138 0.173 0.035
Loading phase
D0 1.071 1.000 0.846 0.669 0.170 0.090 0.277 0.210
D1 1.129 1.017 1.050 0.794 0.132 0.153 0.198 0.128
D2 1.275 1.250 1.042 0.102 0.222 0.138
D3 1.304 1.267 1.146 0.245 0.265 0.208
D4 1.379 1.367 1.088 0.196 0.240 0.173
D5 1.375 1.175 1.033 0.713 0.182 0.377 0.185 0.116
D6 1.388 1.300 1.200 0.262 0.217 0.167
Unloading phase
D7 1.250 1.067 0.771 0.147 0.076 0.257
D8 0.694 0.126
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In this study, both the RGS scale scoring and the mechanical reflex testing were performed for 
pain assessment. The mechanical reflex testing was done before the start of loading on each 
day;  however, the RGS videotapes were recorded daily, 3hours after loading is complete (Figure 
2). So, when looking at those data, comparing the data from the first day of RGS with the data 
from the second day of mechanical reflexing testing is more appropriate than comparing days. 
For example, the D0 of mechanical reflex testing is baseline (applied before loading). Conversely, 
the data at D0 to RGS scoring is in the first day of loading , and measured three hours after 
loading. In addition to different time points, the scoring scale is different between the two 
methods. If pain levels increase, the mechanical sensitivity threshold is decreased but the RGS 
score is increased (Figure 9). However, in both methods, data trends are the same, with 
withdrawal threshold and RGS score reaching extreme values, which indicate pain. Yet, there are 
still some differences between the two assessments. Although withdrawal threshold for the sham 
group is not significantly different before and after isoflurane exposure, the RGS scores are 
slightly elevated over the baseline score. After mechanically-induced TMJ pain, the L2 group has 
a steadily decreasing threshold from D1 to D14 (Figure 9b). On the other hand, the RGS score 
increases with time and peaks on D5 (Figure 9b). The RGS scores on the first two unloading 
days (D7 and D8) returns to lower levels, similar in magnitude to D0 through D3. The scores 
return to sham levels from D10 to D13. From these data, both methods seem to detect pain in 
rats, and the RGS detects minor changes.
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     (a)                                                                              (b)
 
Figure 9. RGS (upper) and mechanical reflex testing (lower) responses. 
(a) The L1 group, the vehicle/naproxen-injected groups and the sham group. (b) The L2 group 
and the sham group. 
#: Significant difference between the loading group and the sham group (p < 0.05)
◎: Significant difference between the loading group and the naproxen-injected group (p < 0.01)
Rats in the L1 and L2 groups were randomly assigned and testing conditions for the two groups 
were the same. The only difference was the digital video recording time points. The RGS scores 
in the L1 group are elevated after the first day after loading (D0 = 1.07±0.17) compared to 
baseline (0.49±0.13), and the RGS scores stay steady throughout the loading phase after loading 
for 3 continuous days (D2 = 1.28±0.10). To test the effect of mechanical TMJ loading, we 
compared the combined L1/L2 group and the sham group at matching time points. The two 
loading groups have significantly higher RGS scores compared with the sham group within the 
loading phase on D5 (Figure 10) (Table 2) (Figure 11) (Table 3). In the loading phase, there are 
no differences until D5. One reason for this may be the limited data from the sham group and that 
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all the time points were not matched in the loading groups. After loading was stopped, the RGS 
score of the L2 group returns to the sham levels on D13 (RGS score: L2 = 0.62±0.21; sham = 
0.60±0.28). 
 
Figure 10. The L1 and sham groups.
#: Significant difference between the loading group and the sham group (p < 0.05)
Table 2. P-values for the L1 group and the sham group
#: Significant difference between the loading group and the sham group (p<0.01)
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 Figure 11. The time course of RGS scores in the L2 group and the sham group.
#: Significant difference between the loading group and the sham group (p < 0.01)
Table 3. RGS scores of the L2 group and the sham group.
#
Mean RGS (0-2) Standard deviation p-value
Loading(n=4) Sham(n=4) Loading Sham
D-2 0.519 0.072
D-1 0.569 0.450 0.118 0.035 1.0000
D0 0.881 0.669 0.414 0.210 0.9896
D1 0.863 0.794 0.359 0.128 1.0000
D3 0.925 0.181
D5 1.319 0.713 0.360 0.116 0.0062
D7 0.950 0.297
D8 0.981 0.694 0.310 0.126 0.8398
D10 0.575 0.249
D12 0.613 0.242
D13 0.619 0.600 0.213 0.280 1.0000
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Lateral tail vein injections of vehicle or naproxen were delivered after loading on D4 and D5. In 
this study, naproxen was hypothesized to reduce TMJ pain. Overall, the RGS scores of the 
vehicle group were not significantly different from the L1 group at any time points (Figure 12) 
(Table 4). However, on D5, the RGS score rebounds back to original levels. This may occur 
because one of the rats in the group had a substantially lower score (0.83) at the time point 
compared to the other two rats (1.13 and 1.58), lowering the average RGS score (1.18±0.38) on 
D5. 
After injection of naproxen, the value of RGS decreased immediately (D4=1.09±0.17, D5= 
1.03±0.18), but was not significantly different from loading or vehicle injection with correction for 
multiple comparisons (Figures 13 and 14) (Tables 5 and 6). Continued loading without naproxen 
injection was performed on D6, at which point the RGS score increased to 1.2±0.17. The 
naproxen-injected group had no significant differences compared to sham at matched time points 
(D-1, D0, D1, D5). Comparison of the vehicle-injected group and the naproxen-injected group, 
also showed no statistical differences (Figure 13) (Table 5).
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 Figure 12. The L1 group and the vehicle-injected group.
Table 4. P-values for the comparison of the L1 group and the vehicle-injected group.
 
Figure 13. The vehicle-injected group and the naproxen-injected group.
Table 5. P-values for the comparison of the vehicle-injected group and the naproxen-
injected group. 
L1&V D-2 D-1 D0 D1 D2 D3 D4 D5 D6 D7
p-value 1.000 1.000 1.000 1.000 1.000 1.000 1.000 0.970 1.000 0.968
V&N D-2 D-1 D0 D1 D2 D3 D4 D5 D6 D7
p-value 1.000 1.000 0.999 1.000 0.972 1.000 0.746 1.000 0.995 0.897
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The RGS scores in the naproxen-injected group continuously decreased on D4 and D5. However, 
there is no statistical differences when compared to the L1 group. The score rebounds to higher 
levels on D6, during which the rats were in the loading phase without injection. Interestingly, the 
RGS score is dramatically lowered, almost to sham levels, on D7 (unloading phase, 0.77±0.26) 
and is significantly different from the L1 group (Figure 14) (Table 6). The large variation in the 
RGS score may contribute to the lack of significant difference between the two injection groups 
on D7. From the results here, naproxen appears to be reducing pain somewhat but higher doses 
may be required to completely resolve pain. The reason why the RGS scores decrease 
significantly after unloading in the naproxen group is still unclear.
 
Figure 14. The L1 group and the naproxen-injected group.
◎: Significant difference between the loading group and the naproxen-injected group (p<0.01)
Table 6. P-values for the comparison of the L1 group and the naproxen-injected group.
◎
L1&N D-2 D-1 D0 D1 D2 D3 D4 D5 D6 D7
p-value 0.985 1.000 0.732 1.000 0.674 0.985 0.268 0.080 0.926 0.001
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The agreement between four trained RGS raters was calculated using the intraclass correlation 
coefficient (ICC). According to prior investigations (Landis et al. 1977, Altman et al. 1990), there 
are five categories of ICC levels indicating agreement: (1) very good (0.81-1.00); (2) good 
(0.61-0.80); (3) moderate (0.41-0.60); (4) fair (0.21-0.40); and (5) poor (<0.20). For the individual 
AUs, orbital tightening is the only highly reliable indicator component when compared to the other 
three AUs (ICC=0.86, very good). The second is whisker change, with moderate level of reliability 
(ICC=0.64). And the nose/cheek flattening and ear change are the two least reliable AUs with fair 
level of reliability (ICC=0.44 and 0.45 respectively). The ICC of the average RGS scores between 
four raters is 0.85, which is represent a “very good” level of reliability (Figure 15) (Table 7) 
(Landis et al. 1977, Altman et al. 1990).
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 Figure 15. RGS scores across four raters.
Table 7. Intraclass correlation coefficients(ICC) of the four raters
The average RGS scores between four raters is 0.85, which is represent a “very good” level of 
reliability. For the individual AUs, orbital tightening is the only highly reliable indicator component 
(ICC=0.86, very good). The second is whisker change, with moderate level of reliability 
(ICC=0.64). And the nose/cheek flattening and ear change are the two least reliable AUs with fair 
level of reliability (ICC=0.44 and 0.45 respectively). 
Overall 
ICC
YHY YHY YHY CLW CLW BAW
CLW BAW BHP BAW BHP BHP
RGS 0.85 0.83 0.90 0.92 0.77 0.85 0.84
Orbital 
tightening
0.86 0.89 0.91 0.87 0.83 0.80 0.88
Nose/
cheek 
flattening
0.44 0.32 0.72 0.56 0.29 0.11 0.52
Ear 
change
0.45 0.16 0.57 0.51 0.14 0.58 0.55
Whisker 
change
0.64 0.38 0.65 0.75 0.76 0.44 0.71
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Discussion 
This is the first study applying RGS to mechanically-induced TMJ pain over an extended 
observation period. From the results, both reflex testing and RGS scoring appear to be alter to 
detect pain in rats subjected to TMJ loading. The withdrawal reflex is a measurement of 
hypersensitivity. However, it might also indicate that the animals want to avoid the stimulus. 
LaBuda and Fuchs found that rats avoid behavior during the first 10-15 minutes of mechanical 
stimulation (LaBuda and Fuchs, 2000). The withdrawal reflex testing is technically sensitive, 
requiring experienced animal handler to apply the test. And the nociceptive reaction acquired 
from the test is not always present as the “actual pain” (Le Bars et al. 2001, Mogil and Crager, 
2004). The RGS scoring is a non-evoked test. It has been used on different pain models but not 
with long-term observation. Most studies using RGS scoring have only a single exposure to 
chemical injection or surgical intervention, with 3 to 48 hours of observation (Sotocinal et al. 2011, 
Oliver et al. 2014, Whittaker et al. 2014). De Rantere's group uses data on day 7, 48 hours after a 
one time exposure to the stimuli (De Rantere et al. 2015). That study, however, recorded data for 
up to 14 days with “per day” as an observation unit instead of “hour”. To our knowledge, there is 
only one study similar to ours with continuous mechanical force applied to the teeth with 
orthodontic device, and RGS scoring on setting days (Liao et al. 2014). That study did not show 
the original data of RGS. Each rat had two RGS scores in a day; a baseline RGS score of the 
day, and another RGS score after activating closed-coil spring. The statistic analyses is based on 
the RGS difference score of the day which is different from the other studies. Previously, our lab 
applied the RGS scoring system to spinal nerve root compression rat model. According to the 
study, the peak of RGS scores appeared at three to six hours after nerve root injury (Philips et al. 
2017). Our choice of videotaping three hours after TMJ loading is based on this evidence.
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This study used female rats. According to clinical studies, the female population has a two-fold 
higher risk of persistent TMJ signs or symptoms compared to males (LeResche et al. 1997, 
Marklund et al. 2010, Anastassaki Kohler et al. 2012).  The baseline RGS scores of our study 
range from 0.32 to 0.57, and the baseline of other studies range from 0.1 to 0.67 (Sotocinal et al. 
2011, Oliver et al. 2014, Liao et al. 2014, Whittaker et al. 2014, De Rantere et al. 2015). Only one 
paper uses equal numbers of male rats and female rats and their baseline scores range from 
0.2-0.4 (Sotocinal et al. 2011). There are two male-only studies, the first one with the same 
baseline range as the Sotocinal study (De Rantere et al. 2015). The other one does not 
mentioned the actual RGS score, but set baseline RGS as 0 with all data subtracted 0.1, so we 
assume their baseline is 0.1 (Liao et al. 2014). One female-only study did not mentioned the 
actual value of RGS scores either. However, the article proposed an “analgesic intervention 
score” from the RGS system and defined values less than 0.67 as “non painful” (Oliver et al. 
2014). The baseline value from their group is assumed to be 0.67. It is interesting to notice that 
the RGS score of the male rats tend to have lower value than the female rats. Though there are 
limited studies or data to discuss the differences of RGS scores between the female rats and the 
male rats, gender may be one issue we have to consider in RGS scores.
De Rantere compared the evoked withdrawal responses with RGS scoring for rats (De Rantere et 
al.2015). Male rats were given a chemical injection or a plantar incision. The peak of pain was the 
same for mechanical reflex testing and RGS. But the withdrawal threshold remained at a lower 
level after RGS values returned to baseline levels. It was concluded that RGS scores showed 
pain caused by inflammatory reaction, while the mechanical reflex testing reflected the response 
to an external insult to the inflammed tissue. The results of De Rantere support the results from 
our study. From the literature, the mechanism of nociceptive pain is know to be different from 
inflammatory pain (Woolf 2010). This may account for the RGS score returning to baseline levels 
sooner than the value of the withdrawal threshold.
 52
The mechanical stimulation can only detect the actual or potential tissue damage but the 
emotional component. The head withdrawal action might just the avoidance to the stimuli, not the 
actual withdrawal reflexes reflect. From previous literature, we know facial expression of 
nonhuman animals are able to tell the emotion (Darwin 1872, Langford et al. 2010). Pain is 
defined as, “an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey et al. 1994). Evoked pain 
assessment method need to contact nonhuman animal directly, the communication between 
human and nonhuman animal might alter the result. RGS is a non-evoked pain assessment tool 
that reduce the chance that interaction between human and nonhuman animal. It is more 
objective way to evaluated the pain. The downside of the RGS system is that workers need to 
spend much more time than evoked pain assessment. Extra works need to be done after finishing 
video recording. We may know more about the pain when combining the two behavior testing 
systems together. 
From the results, the RGS seems to be a useful tool to detect mechanically-induced TMJ pain in 
rats. The advantage of the RGS is in avoiding any interference of providers with subjects and 
reducing stress-induced analgesia (Sorge et al. 2014). Although it might not be a useful tool in the 
clinical situation, the RGS is a good way to quantify the ongoing acute pain in open-jaw rat model. 
There has some limitations. This is a pilot study to transfer the RGS to the TMJ pain model in 
rats, there has some limitations. First, we only include female rats  in this study. Male rats might 
have different RGS scores in the TMJ pain model. Second, this study only has a small sample 
size (n=23). The small sample size means the statistical power is low, which might reduced the 
chance to detect the true effect (Button et al. 2013). Also, the effect of naproxen in this study is 
not obvious. Additional studies are required to increase the dosage of naproxen as well.
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Conclusions 
In this study, pain is evaluated by mechanical reflex testing and RGS after mechanical TMJ 
loading. Also, analgesic interventions was used to detect changes in RGS scoring. Both reflex 
testing and RGS scoring can detect pain in rats subjected to TMJ loading. RGS may help us 
to detect changes earlier than mechanical reflex testing. From this study, we can say that 
orofacial pain can be detected by RGS, which may provide a useful new method to evaluate 
TMJ pain.
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